Compare AXGN & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXGN | NUV |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2013 | N/A |
| Metric | AXGN | NUV |
|---|---|---|
| Price | $39.07 | $9.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $39.25 | N/A |
| AVG Volume (30 Days) | ★ 960.9K | 538.9K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.96% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $225,208,000.00 | N/A |
| Revenue This Year | $20.57 | N/A |
| Revenue Next Year | $16.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.21 | N/A |
| 52 Week Low | $9.22 | $8.45 |
| 52 Week High | $39.99 | $9.26 |
| Indicator | AXGN | NUV |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 51.48 |
| Support Level | $29.48 | $9.12 |
| Resistance Level | $39.99 | $9.24 |
| Average True Range (ATR) | 2.03 | 0.06 |
| MACD | 0.42 | 0.00 |
| Stochastic Oscillator | 88.56 | 66.09 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Nuveen Municipal Value Fund Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide current income exempt from regular federal income tax. The Fund's secondary investment objective is to enhance portfolio value and total return.